Cash · 2011–2025

Vertex Pharmaceuticals cash

$5.1B+11.3% · FY2025

Vertex Pharmaceuticals (VRTX) reported $5.1B in cash for fiscal 2025, +11.3% year on year.

$475M2011$489M2012$569M2013$625M2014$715M2015$1.2B2016$1.7B2017$2.7B2018$3.1B2019$6.0B2020$6.8B2021$10.5B2022$10.4B2023$4.6B2024$5.1B2025
Vertex Pharmaceuticals — Cash, 2011–2025
Fiscal yearCashChangeFiling
FY20252025-12-31$5.1B+11.3%Open →
FY20242024-12-31$4.6B−55.9%Open →
FY20232023-12-31$10.4B−1.3%Open →
FY20222022-12-31$10.5B+54.6%Open →
FY20212021-12-31$6.8B+13.5%Open →
FY20202020-12-31$6.0B+92.6%Open →
FY20192019-12-31$3.1B+17.3%Open →
FY20182018-12-31$2.7B+59.1%Open →
FY20172017-12-31$1.7B+40.7%Open →
FY20162016-12-31$1.2B+65.6%Open →
FY20152015-12-31$715M+14.3%Open →
FY20142014-12-31$625M+9.8%Open →
FY20132013-12-31$569M+16.3%Open →
FY20122012-12-31$489M+3.0%Open →
FY20112011-12-31$475M—Open →

Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +18.4%

Cash at companies of similar size

Full ranking by cash →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Vertex Pharmaceuticals cash |url=https://companiesranked.com/en/company/vertex-pharmaceuticals/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Vertex Pharmaceuticals cash. CompaniesRanked. https://companiesranked.com/en/company/vertex-pharmaceuticals/cash-on-hand

BibTeX

@misc{companiesranked-en-company-vertex-pharmaceuticals-cash-on-hand-2026,
  author       = {{CompaniesRanked}},
  title        = {{Vertex Pharmaceuticals cash}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/vertex-pharmaceuticals/cash-on-hand}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0000875320-26-000259 · August 4, 2026

{{cite web |title=Vertex Pharmaceuticals cash — 10-Q (0000875320-26-000259) |url=https://www.sec.gov/Archives/edgar/data/875320/000087532026000259/vrtx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Vertex Pharmaceuticals overview